Turin, Italy
May 10 - May 11, 2002
Relevant progress has been achieved over the past several years in the field of human reproductive biotechnology. Experimental data obtained in vitro as well as in vivo has been accumulated and has created the need to debate many controversial issues that have arisen. The purpose of this Symposium was to contribute to the discussion of these issues – both from the viewpoint of basic research, as well as clinical application.
OBJECTIVES
At the conclusion of this course, the participant was able to:
- Summarize how new biotechnologies have benefited human reproduction.
- Evaluate the impact of human embryo processing in vitro (assisted hatching, preimplantation genetic diagnosis, blastocyst culture).
- Explain current approaches to identify developmentally competent oocytes and embryos.
- Identify the ethical, psychosocial, social, and genetic issues that exist in modern day human reproductive biotechnology.
This course is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.be.
Biotechnology of Human Reproduction: From Research to Clinical Application is designated for a maximum of 12 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
EACCME credits are recognized as Physician’s Recognition Award by the American Medical Association.
The Royal College of Physicians, London, designates this CME activity for 12 credit hours (Reference #14804).